![Filip Borgions](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Filip Borgions
Technik-/Wissenschafts-/F&E-Leiter bei
ARGENX SE
Profil
Filip Borgions currently works at argenx SE, as Chief Technology Innovation Officer.
Dr. Borgions also formerly worked at Thrombogenics, Inc., as Principal.
Dr. Borgions received his undergraduate degree and doctorate degree from Katholieke Universiteit Leuven.
Aktive Positionen von Filip Borgions
| Unternehmen | Position | Beginn |
|---|---|---|
| ARGENX SE | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 |
Ehemalige bekannte Positionen von Filip Borgions
| Unternehmen | Position | Ende |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Corporate Officer/Principal | - |
Ausbildung von Filip Borgions
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
